STOCK TITAN

DiagnaMed Provides Corporate Update

(Positive)
Tags

DiagnaMed (OTCQB: DGNMF) announced a corporate update as it advances a strategic focus on natural clean hydrogen exploration and development and its proposed transition to GeoHydrogen Corp., subject to regulatory and corporate approvals.

The company appointed Charles Turmel, an energy-focused business lawyer with experience in energy law, natural resources, decarbonization and corporate finance, to its Board of Directors, while director Fabio Chianelli resigned. DiagnaMed is advancing its Temiskaming Natural Hydrogen Project in Ontario, which includes an approximately 11-kilometre corridor of anomalous soil-gas hydrogen readings, including concentrations exceeding 2,000 ppm. In Nova Scotia, the Colchester East Natural Hydrogen Project spans 30 exploration licences totalling 2,104 mineral claims in the Cumberland Basin. The company continues its strategic technical advisory partnership with Québec Innovative Materials for exploration planning and geoscientific support and plans to keep progressing exploration and corporate steps tied to the proposed name change.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – DGNMF

+4.99%
+4.99% Session close to close

In the Aug 24 session, DGNMF gained 4.99%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Board appointment strengthens governance and energy-sector expertise as the Company advances its natural clean hydrogen strategy and proposed transition to GeoHydrogen Corp.

Toronto, Ontario--(Newsfile Corp. - August 24, 2026) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") is pleased to provide a corporate update as it continues to advance its strategic focus on natural clean hydrogen exploration and development.

Appointment of Charles Turmel to the Board of Directors
DiagnaMed is pleased to announce the appointment of Charles Turmel to its Board of Directors.

Mr. Turmel is a business lawyer at Delegatus Legal Services Inc., where his practice focuses on energy law, natural resources and decarbonization, with particular emphasis on the legal, contractual and regulatory issues affecting these sectors. His work includes mandates involving the implementation of energy projects and the development of contractual and regulatory frameworks in the context of the energy transition.

Before joining Delegatus, Mr. Turmel worked at National Bank, where he gained experience in commercial financing, business law and corporate governance. His experience included participation in the structuring of corporate financings and asset-transfer transactions, as well as the preparation of share purchase agreements and due diligence involving corporate documentation.

The Company believes Mr. Turmel's combination of energy-sector legal experience, corporate finance knowledge and governance expertise will be particularly valuable as DiagnaMed advances its natural hydrogen portfolio.

Management Commentary
"Charles joins our Board at an important stage in DiagnaMed's evolution," said John Karagiannidis, Chief Executive Officer. "As we advance our natural hydrogen assets in Ontario and Nova Scotia and work toward our proposed transition to GeoHydrogen Corp., strengthening the Board with experience spanning energy, natural resources, regulatory frameworks, corporate finance and governance is highly complementary to our strategy. We welcome Charles and look forward to his contribution as we execute on the next phase of the Company's growth."

Board Transition
The Company also announces that Fabio Chianelli has resigned as a director of DiagnaMed. The Board of Directors and management thank Mr. Chianelli for his contributions and dedicated service to the Company and wish him the very best in his future endeavours.

Advancing a Focused Natural Hydrogen Strategy
DiagnaMed's corporate strategy is now focused on natural clean hydrogen exploration and development. The Company has announced its intention, subject to regulatory acceptance and applicable corporate approvals, to change its corporate name to GeoHydrogen Corp. The proposed name is intended to align the Company's identity more directly with its strategic focus and long-term mission.

The Company is advancing a portfolio of prospective natural hydrogen projects in Ontario and Nova Scotia. Its Temiskaming Natural Hydrogen Project in Ontario includes an approximately 11-kilometre corridor of anomalous soil-gas hydrogen readings, including concentrations exceeding 2,000 ppm. In Nova Scotia, the Company's Colchester East Natural Hydrogen Project comprises 30 exploration licences totalling 2,104 mineral claims within the prospective Cumberland Basin.

DiagnaMed continues to work with Québec Innovative Materials Corp. (CSE: QIMC) (OTCQB: QIMCF) (FSE: 7FJ) ("QIMC") under its strategic technical advisory partnership. QIMC provides exploration planning, field-program supervision, soil-gas sampling, geoscientific interpretation, structural analysis and integration of geological and geochemical datasets to support priority exploration and drill-target generation.

The Road Ahead
With its portfolio established and its corporate strategy increasingly aligned around natural clean hydrogen, DiagnaMed is focused on disciplined execution. The Company intends to continue advancing exploration across its Ontario and Nova Scotia projects while completing the corporate and regulatory steps associated with its proposed name change to GeoHydrogen Corp., subject to applicable approvals.

About DiagnaMed Holdings Corp.
DiagnaMed Holdings Corp. has announced its intention to change its corporate name to GeoHydrogen Corp., subject to regulatory acceptance and applicable corporate approvals. The Company is advancing prospective natural clean hydrogen projects in Ontario and Nova Scotia through disciplined scientific exploration and strategic technical partnerships.

For further information, please contact:
DiagnaMed Holdings Corp.
John Karagiannidis
Chief Executive Officer
514-726-7058
info@diagnamed.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking information within the meaning of applicable Canadian securities legislation, including statements regarding the proposed corporate name change, regulatory and corporate approvals, the Company's natural hydrogen strategy, its continued partnership with QIMC and planned exploration activities. Forward-looking information is based on assumptions and is subject to known and unknown risks and uncertainties that may cause actual results to differ materially from those anticipated. Forward-looking statements are made as of the date of this news release and, except as required by law, the Company disclaims any obligation to update them.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/311021

FAQ

What corporate changes did DiagnaMed (OTCQB: DGNMF) announce on August 24, 2026?

DiagnaMed announced a board change and reaffirmed its strategic focus on natural clean hydrogen. According to DiagnaMed, Charles Turmel joined the Board of Directors, while director Fabio Chianelli resigned, as the company advances exploration in Ontario and Nova Scotia and prepares a proposed name change.

What does DiagnaMed’s proposed name change to GeoHydrogen Corp. mean for DGNMF investors?

DiagnaMed plans to change its corporate name to GeoHydrogen Corp., subject to regulatory and corporate approvals. According to DiagnaMed, the proposed name is intended to align the company’s identity more closely with its natural clean hydrogen strategy and long-term mission in Ontario and Nova Scotia.

What are the key details of DiagnaMed’s Temiskaming Natural Hydrogen Project in Ontario?

The Temiskaming Natural Hydrogen Project includes an approximately 11-kilometre corridor of anomalous soil-gas hydrogen readings. According to DiagnaMed, this corridor features hydrogen concentrations exceeding 2,000 ppm, supporting its focus on disciplined scientific exploration and priority drill-target generation in Ontario’s natural hydrogen prospects.

What is DiagnaMed’s Colchester East Natural Hydrogen Project in Nova Scotia?

The Colchester East Natural Hydrogen Project consists of 30 exploration licences totalling 2,104 mineral claims. According to DiagnaMed, these licences are located within Nova Scotia’s prospective Cumberland Basin, forming a key part of the company’s portfolio of natural clean hydrogen exploration assets.

Who is Charles Turmel and why was he appointed to DiagnaMed’s Board of Directors?

Charles Turmel is a business lawyer focused on energy law, natural resources and decarbonization. According to DiagnaMed, his experience in regulatory frameworks, energy projects, commercial financing and corporate governance is expected to support the company as it advances its natural hydrogen portfolio and corporate transition plans.

How is Québec Innovative Materials supporting DiagnaMed’s natural hydrogen strategy?

Québec Innovative Materials acts as a strategic technical advisory partner to DiagnaMed. According to DiagnaMed, QIMC provides exploration planning, field-program supervision, soil-gas sampling, geoscientific interpretation, structural analysis and integration of geological and geochemical datasets to support exploration and drill-target generation for its hydrogen projects.

What are DiagnaMed’s next steps in advancing its natural clean hydrogen focus?

DiagnaMed plans to continue advancing exploration across its Ontario and Nova Scotia projects while completing corporate and regulatory steps for the proposed GeoHydrogen Corp. name change. According to DiagnaMed, this reflects an increasing alignment of its corporate strategy around natural clean hydrogen development.